Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences
- Tuesday, September 5, 2023, 7:01
- Finance
- Add a comment
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced that the Company will host investor meetings at…
About the Author
adminasapcorp has written 41538 stories on this site.